InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,205.11
(
-1.08%
)
Post# of 438
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DanWebzster

Send PM Follow Ignore
Followers 10
Posts 1060
Boards Moderated 2
Alias Born 09/04/2000

DanWebzster

Member Level

Re: DanWebzster post# 320

Friday, 08/24/2018 9:02:19 AM

Friday, August 24, 2018 9:02:19 AM

Post# of 438
ADMA markets & develops plasma derived products to treat Primary Immune Deficiency Disease (PIDD) and certain other infectious diseases

10/25/18 PDUFA

After a previous CRL due to mfrng issues at a third party facility, ADMA acquired the mfr and its products then addressed the issues internally

Plasma derived proteins are not subject to patents, instead quant methods to reliably test for appropriate levels of neutralizing antibodies are patentable

CEO & CFO bought a combined 57,000 shares at $4.78

Cash runway is into H2/19.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up